WNY Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$800K Sell
33,220
-658
-2% -$17.2K 0.07% 122
2026
Q1
$951K Buy
+33,878
New +$902K 0.1% 103
2025
Q3
$1.17M Buy
45,892
+6,791
+17% +$168K 0.11% 84
2025
Q2
$948K Buy
39,101
+748
+2% +$17.4K 0.1% 88
2025
Q1
$972K Buy
38,353
+8,667
+29% +$227K 0.12% 92
2024
Q4
$788K Sell
29,686
-9,061
-23% -$246K 0.1% 100
2024
Q3
$1.12M Sell
38,747
-859
-2% -$25.1K 0.13% 84
2024
Q2
$1.11M Buy
39,606
+1,800
+5% +$49.6K 0.15% 90
2024
Q1
$1.05M Sell
37,806
-5,199
-12% -$144K 0.16% 90
2023
Q4
$1.24M Buy
43,005
+1,338
+3% +$40.4K 0.21% 77
2023
Q3
$1.38M Buy
41,667
+5,620
+16% +$199K 0.27% 64
2023
Q2
$1.32M Sell
36,047
-1,194
-3% -$46.5K 0.28% 61
2023
Q1
$1.52M Sell
37,241
-1,393
-4% -$60.2K 0.36% 55
2022
Q4
$1.98M Sell
38,634
-5,358
-12% -$257K 0.54% 46
2022
Q3
$1.93M Sell
43,992
-7,729
-15% -$376K 0.7% 43
2022
Q2
$2.7M Sell
51,721
-1,799
-3% -$91.7K 0.92% 31
2022
Q1
$2.77M Buy
53,520
+1,852
+4% +$96.1K 0.86% 30
2021
Q4
$3.06M Buy
51,668
+3,632
+8% +$180K 0.91% 28
2021
Q3
$2.06M Buy
48,036
+3,182
+7% +$141K 0.71% 36
2021
Q2
$1.76M Buy
44,854
+2,338
+5% +$90.9K 0.63% 35
2021
Q1
$1.54M Buy
42,516
+10,316
+32% +$366K 0.62% 29
2020
Q4
$1.19M Buy
+32,200
New +$1.18M 0.6% 23

Other funds holding PFE

WNY Asset Management's PFE Position: Q2 2026 in Review

WNY Asset Management reduced its Pfizer (PFE) stake by 1.9% in Q2 2026, selling an estimated $17.2K and leaving 33,220 shares worth $800K. The position accounts for 0.07% of the portfolio, ranked #122.

WNY Asset Management first reported a position in PFE in Q4 2020 and has held it in 22 quarters since. The position peaked at $3.06M in Q4 2021. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • WNY Asset Management held 33,220 shares of Pfizer worth $800K as of Q2 2026.
  • WNY Asset Management sold 658 Pfizer shares in Q2 2026, an estimated $17.2K.
  • Pfizer made up 0.07% of WNY Asset Management's portfolio in Q2 2026, its #122 holding.
  • WNY Asset Management first reported a position in Pfizer in Q4 2020 and has held it in 22 quarters since.
  • WNY Asset Management's Pfizer position peaked at $3.06M in Q4 2021.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on WNY Asset Management's 13F filing for Q2 2026, filed 17 Aug 2026.